Atopic Dermatitis
Latest News
Consider gaps in access and knowledge in diagnosis and treatment in skin of color
Expert panel shares best practices for managing common dermatologic conditions in a diverse patient population
Latest News
Serum dupilumab levels do not predict clinical response
In a study of adults with eczema, dupilumab blood levels at 4 months bore no correlation with clinical responses or adverse events during the...
Latest News
Breaking the itch-scratch cycle with mindfulness
Mindful breathing can help interrupt the itch-scratch cycle and relieve pain, stress, and distress often experienced by children, teens, and...
Latest News
Rapid action or sustained effect? Methotrexate vs. ciclosporin for pediatric AD
In the TREAT trial, 103 patients with AD (mean age, 10 years) who had not responded to topical treatment, were randomly assigned to oral...
Latest News
Online support tool improves AD self-management
The intervention, directed either at parents of children with AD or young adults with AD, “is very low cost, evidence based, easily accessible,...
Latest News
An integrative approach to atopic dermatitis features a long list of options
Dr. Lio has three main criteria, or “filters,” for complementary or alternative treatments: At least some clinical evidence for efficacy (...
Latest News
Remote assessment of atopic dermatitis is feasible with patient-provided images: Study
Overall, the main problem with remote assessment seems to be the feasibility of patients providing images, according to the investigator.
Latest News
Dupilumab-associated ocular surface disease in patients with AD: Unraveling the link
In the study, dupilumab treatment was associated with a significant decline in the production of Mucin5AC, suggesting a decline in function of the...
Latest News
Evidence mounting that full-body emollients don’t prevent AD in at-risk babies
“So far, the science does not look convincing,” said the lead investigator, Dr. Hywel C. Williams.
Latest News
Dermatologists fear effects of Dobbs decision for patients on isotretinoin, methotrexate
The iPLEDGE work group has not yet issued any specific statements on the implications of the Dobbs decision on prescribing isotretinoin.
Latest News
Dupilumab study outlines benefits, safety profile in infants, preschoolers with atopic dermatitis
The study was the basis of the Food and Drug Administration expanded approval of dupilumab in June 2022, to include children aged 6 months to 5...